Twist Bioscience Corporation
TWST
$39.96
$0.842.15%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 88.71M | 84.71M | 81.46M | 75.30M | 71.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 88.71M | 84.71M | 81.46M | 75.30M | 71.50M |
| Cost of Revenue | 45.87M | 46.48M | 46.19M | 44.42M | 42.54M |
| Gross Profit | 42.84M | 38.23M | 35.27M | 30.88M | 28.96M |
| SG&A Expenses | 56.18M | 53.14M | 56.79M | 55.62M | 52.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 123.36M | 120.75M | 125.46M | 124.19M | 118.48M |
| Operating Income | -34.64M | -36.04M | -43.99M | -48.89M | -46.98M |
| Income Before Tax | -31.50M | -34.75M | -85.38M | -45.15M | -42.89M |
| Income Tax Expenses | 97.00K | -96.00K | 191.00K | 345.00K | 120.00K |
| Earnings from Continuing Operations | -31.59M | -34.66M | -85.57M | -45.49M | -43.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.59M | -34.66M | -85.57M | -45.49M | -43.01M |
| EBIT | -34.64M | -36.04M | -43.99M | -48.89M | -46.98M |
| EBITDA | -28.26M | -31.99M | -35.69M | -40.59M | -38.81M |
| EPS Basic | -0.53 | -0.59 | -1.47 | -0.79 | -0.75 |
| Normalized Basic EPS | -0.33 | -0.37 | -0.43 | -0.49 | -0.47 |
| EPS Diluted | -0.53 | -0.59 | -1.47 | -0.79 | -0.75 |
| Normalized Diluted EPS | -0.33 | -0.37 | -0.43 | -0.49 | -0.47 |
| Average Basic Shares Outstanding | 59.16M | 58.55M | 58.15M | 57.78M | 57.50M |
| Average Diluted Shares Outstanding | 59.16M | 58.55M | 58.15M | 57.78M | 57.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
